tradingkey.logo
tradingkey.logo
Search

Stereotaxis Inc

STXS
Add to Watchlist
1.790USD
+0.020+1.13%
Close 07/02, 13:00ETQuotes delayed by 15 min
174.50MMarket Cap
LossP/E TTM

More Details of Stereotaxis Inc Company

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.

Stereotaxis Inc Info

Ticker SymbolSTXS
Company nameStereotaxis Inc
IPO dateAug 12, 2004
CEOFischel (David Leo)
Number of employees139
Security typeOrdinary Share
Fiscal year-endAug 12
Address710 N Tucker Blvd
CityST. LOUIS
Stock exchangeNASDAQ OMX – NASDAQ Basic Amex
CountryUnited States of America
Postal code63101
Phone13146786100
Websitehttps://www.stereotaxis.com/
Ticker SymbolSTXS
IPO dateAug 12, 2004
CEOFischel (David Leo)

Company Executives of Stereotaxis Inc

Name
Name/Position
Position
Shareholding
Change
Mr. David W. Benfer
Mr. David W. Benfer
Lead Independent Director
Lead Independent Director
463.30K
-19.56%
Mr. David Leo Fischel
Mr. David Leo Fischel
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
255.00K
+21.57%
Dr. Nathan Fischel, M.D.
Dr. Nathan Fischel, M.D.
Director
Director
254.50K
-12.03%
Mr. Ross B. Levin
Mr. Ross B. Levin
Independent Director
Independent Director
154.97K
-19.76%
Mr. Nachum (Homi) Shamir
Mr. Nachum (Homi) Shamir
Director
Director
136.22K
+34.46%
Dr. Arun Swarup Menawat, Ph.D.
Dr. Arun Swarup Menawat, Ph.D.
Independent Director
Independent Director
--
--
Ms. Kimberly R. Peery
Ms. Kimberly R. Peery
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Myriam J. Curet, M.D.
Dr. Myriam J. Curet, M.D.
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. David W. Benfer
Mr. David W. Benfer
Lead Independent Director
Lead Independent Director
463.30K
-19.56%
Mr. David Leo Fischel
Mr. David Leo Fischel
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
255.00K
+21.57%
Dr. Nathan Fischel, M.D.
Dr. Nathan Fischel, M.D.
Director
Director
254.50K
-12.03%
Mr. Ross B. Levin
Mr. Ross B. Levin
Independent Director
Independent Director
154.97K
-19.76%
Mr. Nachum (Homi) Shamir
Mr. Nachum (Homi) Shamir
Director
Director
136.22K
+34.46%
Dr. Arun Swarup Menawat, Ph.D.
Dr. Arun Swarup Menawat, Ph.D.
Independent Director
Independent Director
--
--

FAQs

Who are the top five shareholders of Stereotaxis Inc?

The top five shareholders of Stereotaxis Inc are: Mr. David W. Benfer

How many institutions hold shares of Stereotaxis Inc (STXS)?

As of 2026Q1, 205 institutions hold shares of Stereotaxis Inc, with a combined market value of approximately 49.70M, accounting for 50.99% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 2238158.00.